ABBV · AbbVie GP
last $263.39-0.66%volume $5.13Mmarket cap n/afeed alpacaas of 2026-09-25 15:30
one year · daily closes52-week high $266.1052-week low $197.371m -0.2%3m +9.0%1y +20.5%
FA · financials · AbbVie Inc. from the company's own filingsEDGAR ↗
| quarter ending | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| revenue | $16.99B | $15.00B | $16.62B | $15.78B | $15.42B | $13.34B | $15.10B | $14.46B |
| net income | $3.61B | $695.00M | $1.82B | $186.00M | $938.00M | $1.29B | $-22.00M | $1.56B |
| EPS (diluted) | 2.03 | 0.39 | 1.02 | 0.10 | 0.52 | 0.72 | -0.02 | 0.88 |
| operating cash flow | $3.44B | $3.83B | $5.22B | $7.02B | $5.15B | $1.64B | $7.05B | $5.45B |
total assets $135.12B (2026-06-30)cash $6.57B (2026-06-30)long term debt $64.50B (2025-12-31)equity $-5,935,000,000 (2026-06-30)shares outstanding 1,767,117,285 (2026-07-27)
quarterly figures as filed (10-Q / 10-K); where a company reports year-to-date, the quarter is the difference. No estimates.
news · ABBVmore →
no matching headlines in the last hours